523 related articles for article (PubMed ID: 31981976)
1. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
Xu J; Chang WS; Tsai CW; Bau DT; Xu Y; Davis JW; Thompson TC; Logothetis CJ; Gu J
EBioMedicine; 2020 Feb; 52():102616. PubMed ID: 31981976
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte telomere length is associated with aggressive prostate cancer in localized African American prostate cancer patients.
Tsai CW; Chang WS; Xu J; Xu Y; Huang M; Pettaway C; Bau DT; Gu J
Carcinogenesis; 2020 Sep; 41(9):1213-1218. PubMed ID: 32614411
[TBL] [Abstract][Full Text] [Related]
3. Relative telomere length and prostate cancer mortality.
Renner W; Krenn-Pilko S; Gruber HJ; Herrmann M; Langsenlehner T
Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):579-583. PubMed ID: 30082901
[TBL] [Abstract][Full Text] [Related]
4. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer.
Julin B; Shui I; Heaphy CM; Joshu CE; Meeker AK; Giovannucci E; De Vivo I; Platz EA
Br J Cancer; 2015 Feb; 112(4):769-76. PubMed ID: 25562437
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of leukocyte telomere length in renal cell carcinoma patients.
Chen M; Tsai CW; Chang WS; Xu J; Xu Y; Bau DT; Gu J
Am J Cancer Res; 2020; 10(10):3428-3439. PubMed ID: 33163281
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte Telomere Length and the Risk of Prostate Cancer and Benign Prostatic Hyperplasia: Insights From UK Biobank and Mendelian Randomization Study.
Lv K; Wu Y; Yang G; Hao X; Huang S; Song T; Yuan Q
J Gerontol A Biol Sci Med Sci; 2024 Mar; 79(3):. PubMed ID: 38085929
[TBL] [Abstract][Full Text] [Related]
8. Mendelian randomization study on the causal relationship between leukocyte telomere length and prostate cancer.
Wan B; Lu L; Lv C
PLoS One; 2023; 18(6):e0286219. PubMed ID: 37352282
[TBL] [Abstract][Full Text] [Related]
9. Methylation of subtelomeric repeat D4Z4 in peripheral blood leukocytes is associated with biochemical recurrence in localized prostate cancer patients.
Han Y; Xu J; Kim J; Wu X; Gu J
Carcinogenesis; 2017 Aug; 38(8):821-826. PubMed ID: 28854562
[TBL] [Abstract][Full Text] [Related]
10. Association of leukocyte telomere length in peripheral blood leukocytes with endometrial cancer risk in Caucasian Americans.
Sun Y; Zhang L; Zhao L; Wu X; Gu J
Carcinogenesis; 2015 Nov; 36(11):1327-32. PubMed ID: 26385889
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte Telomere Length and Bladder Cancer Risk: A Large Case-Control Study and Mendelian Randomization Analysis.
Chen M; Xu Y; Xu J; Chancoco H; Gu J
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):203-209. PubMed ID: 32998948
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer.
Tu H; Gu J; Meng QH; Kim J; Davis JW; He Y; Wagar EA; Thompson TC; Logothetis CJ; Wu X
Oncotarget; 2015 Dec; 6(39):41988-96. PubMed ID: 26515605
[TBL] [Abstract][Full Text] [Related]
13. A Family History of Lethal Prostate Cancer and Risk of Aggressive Prostate Cancer in Patients Undergoing Radical Prostatectomy.
Raheem OA; Cohen SA; Parsons JK; Palazzi KL; Kane CJ
Sci Rep; 2015 Jun; 5():10544. PubMed ID: 26112134
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of tertiary Gleason pattern 5 in a contemporary grading system for prostate cancer.
Jang WS; Yoon CY; Kim MS; Kang DH; Kang YJ; Jeong WS; Abalajon MJ; Ham WS; Choi YD
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):93-98. PubMed ID: 27845330
[TBL] [Abstract][Full Text] [Related]
15. Long Leukocyte Telomere Length Is Associated with Increased Risks of Soft Tissue Sarcoma: A Mendelian Randomization Study.
Xu Y; Xu J; Chancoco H; Huang M; Torres KE; Gu J
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32150919
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African Americans.
Xu J; Chang WS; Tsai CW; Bau DT; Davis JW; Thompson TC; Logothetis CJ; Gu J
Carcinogenesis; 2020 May; 41(3):267-273. PubMed ID: 31408512
[TBL] [Abstract][Full Text] [Related]
17. Predicted leukocyte telomere length and risk of myeloid neoplasms.
Sullivan SM; Cole B; Lane J; Meredith JJ; Langer E; Hooten AJ; Roesler M; McGraw KL; Pankratz N; Poynter JN
Hum Mol Genet; 2023 Oct; 32(20):2996-3005. PubMed ID: 37531260
[TBL] [Abstract][Full Text] [Related]
18. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of serum CXCL4L1 predicts progression and poor prognosis in prostate cancer patients treated by radical prostatectomy.
Zhang M; Guan J; Huo YL; Song YS; Chen LZ
Asian J Androl; 2019; 21(4):387-392. PubMed ID: 30860083
[TBL] [Abstract][Full Text] [Related]
20. Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.
Bau DT; Lippman SM; Xu E; Gong Y; Lee JJ; Wu X; Gu J
Cancer; 2013 Dec; 119(24):4277-83. PubMed ID: 24105340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
